Role of SOX9 BMI1 in adult neural stem cells and in glioma stem cells
Cancers display remarkable phenotypical and functional intratumoral heterogeneity. The discovery of a rare subpopulation of tumor cells that acquired stem cells properties in several malignancies has profound implications for canc...
ver más
¿Tienes un proyecto y buscas un partner? Gracias a nuestro motor inteligente podemos recomendarte los mejores socios y ponerte en contacto con ellos. Te lo explicamos en este video
Proyectos interesantes
SAF2009-07259
CARACTERIZACION DE CELULAS TRONCALES TUMORALES DE GLIOBLASTO...
182K€
Cerrado
PID2020-118464RB-I00
DECONSTRUYENDO LA IMPLICACION DE SOX2 EN RESISTENCIA A LA TE...
158K€
Cerrado
GNS_cells
Biochemical and functional studies of lineage specific trans...
200K€
Cerrado
CancerHetero
Dissection of tumor heterogeneity in vivo
2M€
Cerrado
BFU2009-14616
FACTORES DE MANTENIMIENTO Y DIFERENCIACION DE CELULAS MADRE...
145K€
Cerrado
GAMNG
Identification of the genetic and or epigenetic events that...
75K€
Cerrado
Fecha límite de participación
Sin fecha límite de participación.
Descripción del proyecto
Cancers display remarkable phenotypical and functional intratumoral heterogeneity. The discovery of a rare subpopulation of tumor cells that acquired stem cells properties in several malignancies has profound implications for cancer therapy. These cells are suppose to be responsible for the origin, progression and recurrence of the tumors. Thus, new strategies directly targeting cancer stem cells should be important for cancer treatment. Glioblastoma multiforme, the most common and malignant brain primary cancer, present very low success rate in the actual therapeutic protocols and the average survival for patients do not exceed a year of life. This can be partially explained because they contain a population of glioma stem cells.
Factors involved in establishing and maintaining stem cells of normal tissues are activated as part of the tumorigenic process. It is likely that these stem cell factors are important for providing and maintaining the characteristics of cancer stem cells. SOX9 and BMI1 are transcriptor factors essential in multiple processes during embryonic development and in the regulation of stem cells in various tissues including the brain. Both are often overexpressed in cancer, mainly in tissues where they plays critical roles in stem/progenitor cells. Our group has recently identified that BMI1 is a direct downstream target of SOX9. The goals of this translational research project is investigate the clinical relevance of SOX9-BMI1 in glioblastoma, characterize its role in the regulation of glioma stem cells and determine whether Sox9-Bmi1 concomitant overexpression is sufficient to induce neural stem cell transformation and cause gliomas. To achieve our aims, we will generate a unique set of cellular and animal models to study in vitro and in vivo the biology of neural and glioma stem cells